These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 24463085)
1. KAI1 inhibits lymphangiogenesis and lymphatic metastasis of pancreatic cancer in vivo. Liu X; Guo XZ; Li HY; Chen J; Ren LN; Wu CY Hepatobiliary Pancreat Dis Int; 2014 Feb; 13(1):87-92. PubMed ID: 24463085 [TBL] [Abstract][Full Text] [Related]
2. KAI1 reverses the epithelial-mesenchymal transition in human pancreatic cancer cells. Liu X; Guo XZ; Li HY; Chen J Hepatobiliary Pancreat Dis Int; 2019 Oct; 18(5):471-477. PubMed ID: 30948327 [TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial growth factor-C secreted by pancreatic cancer cell line promotes lymphatic endothelial cell migration in an in vitro model of tumor lymphangiogenesis. Ochi N; Matsuo Y; Sawai H; Yasuda A; Takahashi H; Sato M; Funahashi H; Okada Y; Manabe T Pancreas; 2007 May; 34(4):444-51. PubMed ID: 17446844 [TBL] [Abstract][Full Text] [Related]
4. Rapamycin, a specific inhibitor of the mammalian target of rapamycin, suppresses lymphangiogenesis and lymphatic metastasis. Kobayashi S; Kishimoto T; Kamata S; Otsuka M; Miyazaki M; Ishikura H Cancer Sci; 2007 May; 98(5):726-33. PubMed ID: 17425689 [TBL] [Abstract][Full Text] [Related]
5. KAI1 is a potential target for anti-metastasis in pancreatic cancer cells. Xu JH; Guo XZ; Ren LN; Shao LC; Liu MP World J Gastroenterol; 2008 Feb; 14(7):1126-32. PubMed ID: 18286698 [TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factor-D induces lymphangiogenesis and lymphatic metastasis in models of ductal pancreatic cancer. Von Marschall Z; Scholz A; Stacker SA; Achen MG; Jackson DG; Alves F; Schirner M; Haberey M; Thierauch KH; Wiedenmann B; Rosewicz S Int J Oncol; 2005 Sep; 27(3):669-79. PubMed ID: 16077915 [TBL] [Abstract][Full Text] [Related]
7. Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling. He Y; Kozaki K; Karpanen T; Koshikawa K; Yla-Herttuala S; Takahashi T; Alitalo K J Natl Cancer Inst; 2002 Jun; 94(11):819-25. PubMed ID: 12048269 [TBL] [Abstract][Full Text] [Related]
8. Src/STAT3 signaling pathways are involved in KAI1-induced downregulation of VEGF-C expression in pancreatic cancer. Liu X; Guo X; Li H; Chen J; Qi X Mol Med Rep; 2016 Jun; 13(6):4774-8. PubMed ID: 27082851 [TBL] [Abstract][Full Text] [Related]
9. Numb/Notch signaling pathway modulation enhances human pancreatic cancer cell radiosensitivity. Bi YL; Min M; Shen W; Liu Y Tumour Biol; 2016 Nov; 37(11):15145-15155. PubMed ID: 27677287 [TBL] [Abstract][Full Text] [Related]
10. A potential small-molecule synthetic antilymphangiogenic agent norcantharidin inhibits tumor growth and lymphangiogenesis of human colonic adenocarcinomas through blocking VEGF-A,-C,-D/VEGFR-2,-3 "multi-points priming" mechanisms in vitro and in vivo. Li XP; Jing W; Sun JJ; Liu ZY; Zhang JT; Sun W; Zhu W; Fan YZ BMC Cancer; 2015 Jul; 15():527. PubMed ID: 26187792 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of cyclooxygenase-2 suppresses lymph node metastasis via VEGF-C. Liu H; Yang Y; Xiao J; Lv Y; Liu Y; Yang H; Zhao L Anat Rec (Hoboken); 2009 Oct; 292(10):1577-83. PubMed ID: 19685508 [TBL] [Abstract][Full Text] [Related]
12. [Expression of vascular endothelial growth factor C in pancreatic cancer and its effect upon lymph node metastasis]. Li K; Li MJ; He T; Zheng Z; Zheng XL; Qu BH; Wang Y; Duan X; Zheng YJ Zhonghua Yi Xue Za Zhi; 2009 Sep; 89(34):2386-90. PubMed ID: 20137690 [TBL] [Abstract][Full Text] [Related]
14. Apoptotic activity and antitumor efficacy of PEGylated TNF-related apoptosis-inducing ligand (TRAIL) in a Mia Paca-2 cell-xenografted mouse model. Byeon HJ; Choi SH; Choi JS; Kim TH; Lee ES; Lee KC; Youn YS Biomed Pharmacother; 2014 Feb; 68(1):65-9. PubMed ID: 24268811 [TBL] [Abstract][Full Text] [Related]
15. A small molecular agent YL529 inhibits VEGF-D-induced lymphangiogenesis and metastasis in preclinical tumor models in addition to its known antitumor activities. Xu Y; Lu W; Yang P; Peng W; Wang C; Li M; Li Y; Li G; Meng N; Lin H; Kan L; Wang S; Yang S; Yu L; Zhao Y BMC Cancer; 2015 Jul; 15():525. PubMed ID: 26187637 [TBL] [Abstract][Full Text] [Related]
16. Reduced KAI1 expression in pancreatic cancer is associated with lymph node and distant metastases. Friess H; Guo XZ; Berberat P; Graber HU; Zimmermann A; Korc M; Büchler MW Int J Cancer; 1998 Aug; 79(4):349-55. PubMed ID: 9699525 [TBL] [Abstract][Full Text] [Related]
17. COX-2-mediated regulation of VEGF-C in association with lymphangiogenesis and lymph node metastasis in lung cancer. Liu H; Yang Y; Xiao J; Lv Y; Liu Y; Yang H; Zhao L Anat Rec (Hoboken); 2010 Nov; 293(11):1838-46. PubMed ID: 20830783 [TBL] [Abstract][Full Text] [Related]
18. Liposomal honokiol inhibits VEGF-D-induced lymphangiogenesis and metastasis in xenograft tumor model. Wen J; Fu AF; Chen LJ; Xie XJ; Yang GL; Chen XC; Wang YS; Li J; Chen P; Tang MH; Shao XM; Lu Y; Zhao X; Wei YQ Int J Cancer; 2009 Jun; 124(11):2709-18. PubMed ID: 19219913 [TBL] [Abstract][Full Text] [Related]
19. Roles of KAI1 and nm23 in lymphangiogenesis and lymph metastasis of laryngeal squamous cell carcinoma. Zheng Z; Tian R; Wang P World J Surg Oncol; 2017 Nov; 15(1):211. PubMed ID: 29187211 [TBL] [Abstract][Full Text] [Related]
20. Nerve growth factor exerts differential effects on the growth of human pancreatic cancer cells. Zhu ZW; Friess H; Wang L; Bogardus T; Korc M; Kleeff J; Büchler MW Clin Cancer Res; 2001 Jan; 7(1):105-12. PubMed ID: 11205897 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]